4//SEC Filing
Kummerfeld Keith C 4
Accession 0001193805-23-001002
CIK 0001768224other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 6:50 PM ET
Size
16.4 KB
Accession
0001193805-23-001002
Insider Transaction Report
Form 4
Kummerfeld Keith C
See Remarks
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2023-07-14−1,031→ 7,938 totalExercise: $14.12Exp: 2030-02-18→ Common Stock (1,031 underlying) - Exercise/Conversion
Common Stock
2023-07-14$9.04/sh+4,500$40,680→ 5,450 total - Exercise/Conversion
Common Stock
2023-07-14$4.99/sh+1,437$7,171→ 6,887 total - Sale
Common Stock
2023-07-14$35.00/sh−6,968$243,880→ 950 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-07-14−4,500→ 21,000 totalExercise: $9.04Exp: 2028-07-04→ Common Stock (4,500 underlying) - Exercise/Conversion
Common Stock
2023-07-14$14.12/sh+1,031$14,558→ 7,918 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-07-14−1,437→ 7,126 totalExercise: $4.99Exp: 2029-02-06→ Common Stock (1,437 underlying)
Footnotes (3)
- [F1]Represents shares sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]These shares were sold in multiple transactions, each at a price of $35.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it on July 14, 2023.
- [F3]25% of the shares underlying the options vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter.
Documents
Issuer
Arcturus Therapeutics Holdings Inc.
CIK 0001768224
Entity typeother
Related Parties
1- filerCIK 0001762749
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 6:50 PM ET
- Size
- 16.4 KB